How to Achieve International Action on Falsified and Substandard Medicines
BMJ, 2012, DOI: 10.1136/bmj.e7381
6 Pages Posted: 20 Nov 2012
Date Written: November 1, 2012
Abstract
Substandard and falsified medicines kill patients, yet progress on the twin challenges of safeguarding the quality of genuine medicine and criminalising falsified ones has been held back by controversy over intellectual property rights and confusion over terms. Amir Attaran and colleagues propose a global treaty to overcome the problems.
Keywords: substandard medicines, falsified medicines, global treaty
Suggested Citation: Suggested Citation
Attaran, Amir and Attaran, Amir and Barry, Donna and Basheer, Shamnad and Bate, Roger and Benton, David and Chauvin, James and Garrett, Laurie and Kickbusch, Ilona and Kohler, Jillian C. and Midha, Kamal and Newton, Paul and Nishtar, Sania and Orhii, Paul and McKee, Martin, How to Achieve International Action on Falsified and Substandard Medicines (November 1, 2012). BMJ, 2012, DOI: 10.1136/bmj.e7381, Available at SSRN: https://ssrn.com/abstract=2178601
Do you have negative results from your research you’d like to share?
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.